These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27518758)
21. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties. Shareef MA; Duscharla D; Ramasatyaveni G; Dhoke NR; Das A; Ummanni R; Srivastava AK Eur J Med Chem; 2015 Jan; 89():128-37. PubMed ID: 25462233 [TBL] [Abstract][Full Text] [Related]
22. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain. Zhao W; He L; Xiang TL; Tang YJ Eur J Med Chem; 2019 May; 170():73-86. PubMed ID: 30878833 [TBL] [Abstract][Full Text] [Related]
23. Identification of potent virtual leads and ADME prediction of isoxazolidine podophyllotoxin derivatives as topoisomerase II and tubulin inhibitors. Bkhaitan MM; Mirza AZ; Shamshad H; Ali HI J Mol Graph Model; 2017 May; 73():74-93. PubMed ID: 28242581 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053 [TBL] [Abstract][Full Text] [Related]
25. Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin. Sackett DL Pharmacol Ther; 1993 Aug; 59(2):163-228. PubMed ID: 8278462 [TBL] [Abstract][Full Text] [Related]
26. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin. Kim DY; Kim KH; Kim ND; Lee KY; Han CK; Yoon JH; Moon SK; Lee SS; Seong BL J Med Chem; 2006 Sep; 49(19):5664-70. PubMed ID: 16970393 [TBL] [Abstract][Full Text] [Related]
27. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents. Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and antimitotic and tubulin interaction profiles of novel pinacol derivatives of podophyllotoxins. Abad A; López-Pérez JL; del Olmo E; García-Fernández LF; Francesch A; Trigili C; Barasoain I; Andreu JM; Díaz JF; San Feliciano A J Med Chem; 2012 Aug; 55(15):6724-37. PubMed ID: 22607205 [TBL] [Abstract][Full Text] [Related]
29. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues. Gupta RS Cancer Res; 1983 Feb; 43(2):505-12. PubMed ID: 6848174 [TBL] [Abstract][Full Text] [Related]
30. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171 [TBL] [Abstract][Full Text] [Related]
31. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells. Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637 [TBL] [Abstract][Full Text] [Related]
32. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues. Desbène S; Giorgi-Renault S Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752 [TBL] [Abstract][Full Text] [Related]
33. Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry. Imperio D; Pirali T; Galli U; Pagliai F; Cafici L; Canonico PL; Sorba G; Genazzani AA; Tron GC Bioorg Med Chem; 2007 Nov; 15(21):6748-57. PubMed ID: 17765552 [TBL] [Abstract][Full Text] [Related]
34. Development of a novel class of tubulin inhibitors with promising anticancer activities. Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368 [TBL] [Abstract][Full Text] [Related]
35. Morpholino derivatives of benzyl-benzodioxole, a study of structural requirements for drug interactions at the colchicine/podophyllotoxin binding site of tubulin. Batra JK; Jurd L; Hamel E Biochem Pharmacol; 1986 Nov; 35(22):4013-8. PubMed ID: 3778522 [TBL] [Abstract][Full Text] [Related]
36. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs. Kelleher JK Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303 [TBL] [Abstract][Full Text] [Related]
37. Methylenedioxy-benzopyran analogs of podophyllotoxin, a new synthetic class of antimitotic agents that inhibit tubulin polymerization. Batra JK; Kang GJ; Jurd L; Hamel E Biochem Pharmacol; 1988 Jul; 37(13):2595-602. PubMed ID: 3390218 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of benzo[b]furo[3,4-e][1,4]diazepin-1-one derivatives as anti-cancer agents. Malayeri SO; Tayarani-Najaran Z; Behbahani FS; Rashidi R; Delpazir S; Ghodsi R Bioorg Chem; 2018 Oct; 80():631-638. PubMed ID: 30041139 [TBL] [Abstract][Full Text] [Related]
39. Interactions of the tau-tubulin-vinblastine complex with colchicine, podophyllotoxin, and N,N'-ethylenebis(iodoacetamide). Palanivelu P; Ludueña RF J Biol Chem; 1982 Jun; 257(11):6311-5. PubMed ID: 6804464 [TBL] [Abstract][Full Text] [Related]
40. Cytotoxic activity of a synthetic deoxypodophyllotoxin derivative with an opened D-ring. Chen C; Wang CC; Wang Z; Geng WY; Xu H; Song XM; Luo DQ J Asian Nat Prod Res; 2016 May; 18(5):486-94. PubMed ID: 27123550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]